BSE Live
Oct 10, 16:01Prev. Close
1590.35
Open Price
1626.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:55Prev. Close
1592.40
Open Price
1599.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1596.00 (60)
Balance Sheet of Eris Lifesciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 13.58 | 13.75 | 13.75 | 13.75 | 0.14 | |
Total Share Capital | 13.58 | 13.75 | 13.75 | 13.75 | 0.14 | |
Reserves and Surplus | 1,286.12 | 1,142.26 | 854.43 | 560.85 | 305.21 | |
Total Reserves and Surplus | 1,286.12 | 1,142.26 | 854.43 | 560.85 | 305.21 | |
Total Shareholders Funds | 1,299.70 | 1,156.01 | 868.18 | 574.60 | 305.35 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 273.69 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 9.85 | 7.25 | 2.88 | 2.75 | 2.49 | |
Long Term Provisions | 24.13 | 16.47 | 15.02 | 18.54 | 23.10 | |
Total Non-Current Liabilities | 33.99 | 23.73 | 291.58 | 21.28 | 25.58 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 89.93 | 74.93 | 79.03 | 25.11 | 27.89 | |
Other Current Liabilities | 29.76 | 196.50 | 115.17 | 14.68 | 25.38 | |
Short Term Provisions | 29.76 | 19.22 | 16.01 | 21.02 | 17.91 | |
Total Current Liabilities | 149.44 | 290.65 | 210.21 | 60.80 | 71.18 | |
Total Capital And Liabilities | 1,483.13 | 1,470.38 | 1,369.98 | 656.69 | 402.12 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 84.03 | 53.83 | 50.49 | 53.75 | 64.10 | |
Intangible Assets | 516.62 | 430.01 | 439.26 | 38.03 | 0.70 | |
Capital Work-In-Progress | 0.00 | 0.75 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 605.01 | 486.58 | 489.75 | 91.78 | 64.79 | |
Non-Current Investments | 246.03 | 274.36 | 451.84 | 290.43 | 62.60 | |
Deferred Tax Assets [Net] | 164.17 | 137.78 | 95.25 | 45.50 | 5.41 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 32.30 | |
Other Non-Current Assets | 18.33 | 21.88 | 16.95 | 15.83 | 0.00 | |
Total Non-Current Assets | 1,033.53 | 920.60 | 1,053.79 | 443.53 | 165.10 | |
CURRENT ASSETS | ||||||
Current Investments | 74.27 | 306.11 | 93.76 | 90.18 | 143.73 | |
Inventories | 65.46 | 74.70 | 57.52 | 47.20 | 49.46 | |
Trade Receivables | 140.82 | 75.90 | 60.50 | 41.30 | 25.36 | |
Cash And Cash Equivalents | 64.95 | 6.47 | 8.81 | 2.06 | 8.53 | |
Short Term Loans And Advances | 1.87 | 2.04 | 40.37 | 15.81 | 9.70 | |
OtherCurrentAssets | 102.22 | 84.57 | 55.23 | 16.61 | 0.24 | |
Total Current Assets | 449.60 | 549.78 | 316.19 | 213.15 | 237.02 | |
Total Assets | 1,483.13 | 1,470.38 | 1,369.98 | 656.69 | 402.12 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 15.81 | 15.29 | 14.12 | 12.90 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.91 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.91 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 98.27 | 22.99 | 2.78 | 2.06 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 13.44 | 13.61 | 13.61 | 13.61 | 0.10 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.34 | 1.93 | 1.76 | 1.62 | 1.16 | |
Non-Current Investments Unquoted Book Value | 245.69 | 272.43 | 269.85 | 211.43 | 61.10 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 74.27 | 306.11 | 93.76 | 90.18 | 143.73 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher